NextCode Health Platform Will Be Used By Claritas Genomics And Might Improve Duchenne Muscular Dystrophy Diagnosis

Claritas Genomics announced that it will be using the NextCode Health’s integrated and clinical research platform to analyze sequencing-based clinical diagnostic tests. This partnership will allow Claritas to interpret its genome analysis faster and more efficiently so that tests and results can be delivered earlier, improving diagnosis of diseases such as duchenne muscular…